Zobrazeno 1 - 10
of 131
pro vyhledávání: '"Rajneesh, Nath"'
Autor:
Boglarka Gyurkocza, Stuart Seropian, Hannah Choe, Mark Litzow, Camille Abboud, Nebu Koshy, Patrick Stiff, Benjamin Tomlinson, Sunil Abhyankar, James M Foran, Parameswaran Hari, George Chen, Zaid Al-Kadhimi, Partow Kebriaei, Mitchell Sabloff, Johnnie Orozco, Katarzyna Jamieson, Margarida Silverman, Koen Van Besien, Michael Schuster, Arjun Law, Sameem Abedin, Karilyn Larkin, Scott Rowley, Pashna Munshi, Rachel Cook, Sebastian Mayer, Moshe Yair Levy, Hillard Lazarus, Brenda Sandmaier, Vijay Reddy, Jennifer Spross, Kathleen Mcnamara, Elaina Haeuber, Madhuri Vusirikala, Akash Nahar, John Pagel, Sergio Giralt, Avinash Desai, Rajneesh Nath
Publikováno v:
HemaSphere, Vol 7, p e2941723 (2023)
Externí odkaz:
https://doaj.org/article/40f049091be74a68a790fad6e86ff8be
Autor:
Javier Munoz, Frederick Locke, Lazaros Lekakis, Herbert Eradat, Michael Tees, Sven de Vos, Rajneesh Nath, Don Stevens, Shahbaz Malik, Leslie Popplewell, Mehdi Hamadani, Olalekan Oluwole, Miguel-Angel Perales, David Miklos, Paul Fisher, Lovely Goyal, Lynn Navale, Gregory Kaufman, Kazuharu Kai, Arun Balakumaran, Sattva Neelapu
Publikováno v:
HemaSphere, Vol 7, p e8808264 (2023)
Externí odkaz:
https://doaj.org/article/862aabdc556345c085b2dd16ce99e9bc
Publikováno v:
Leukemia Research Reports, Vol 19, Iss , Pp 100370- (2023)
We report a case of myeloid/lymphoid neoplasm with ZMYM2::FGFR1 rearrangement (MLNZMYM2::FGFR1) exhibiting a complex disease evolution. This neoplasm initially presented as T-lymphoblastic lymphoma (T-LBL) in lymph node and myeloproliferative neoplas
Externí odkaz:
https://doaj.org/article/8f381c075c2d405d8178ef9f11a29d25
Autor:
William Selove, Lloyd Hutchinson, Vladislav Makarenko, Xiuling Meng, Keith Tomaszewicz, Muthalagu Ramanathan, Jan Cerny, Rajneesh Nath, Benjamin Chen, Bruce Woda, Jacob R. Bledsoe
Publikováno v:
eJHaem, Vol 2, Iss 3, Pp 514-519 (2021)
Externí odkaz:
https://doaj.org/article/3e2c7ff713464fe38472b9e6765b9794
Autor:
Sham Mailankody, Jeffrey V. Matous, Saurabh Chhabra, Michaela Liedtke, Surbhi Sidana, Olalekan O. Oluwole, Shahbaz Malik, Rajneesh Nath, Faiz Anwer, Jose Carlos Cruz, Myo Htut, Erin E. Karski, Wade Lovelace, Myles Dillon, Eric Butz, Wendy Ying, Arun Balakumaran, Shaji K. Kumar
Publikováno v:
Nature Medicine. 29:422-429
Autor:
Alison, Sehgal, Daanish, Hoda, Peter A, Riedell, Nilanjan, Ghosh, Mehdi, Hamadani, Gerhard C, Hildebrandt, John E, Godwin, Patrick M, Reagan, Nina, Wagner-Johnston, James, Essell, Rajneesh, Nath, Scott R, Solomon, Rebecca, Champion, Edward, Licitra, Suzanne, Fanning, Neel, Gupta, Ronald, Dubowy, Aleco, D'Andrea, Lei, Wang, Ken, Ogasawara, Jerill, Thorpe, Leo I, Gordon
Publikováno v:
The Lancet Oncology. 23:1066-1077
Patients with relapsed or refractory large B-cell lymphoma after first-line treatment who are not intended for haematopoietic stem-cell transplantation (HSCT) have poor outcomes and limited treatment options. We assessed the antitumour activity and s
Autor:
Philippe Moreau, Jesús F. San-Miguel, Anil Singhal, Bruno Paiva, Anita Reddy, James P. Sheridan, Scott Gulbranson, Shekman Wong, Katja Weisel, Xavier Leleu, Andrzej J. Jakubowiak, Joaquín Martínez-López, Andreas Guenther, Marc S. Raab, Jesús G. Berdeja, María-Victoria Mateos, Daniel E.H. Afar, Rajneesh Nath, Ravi Vij
Overall summary of treatment-emergent adverse events
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::072e401dc2fdc93db09c050b8ac6354a
https://doi.org/10.1158/1078-0432.22471553.v1
https://doi.org/10.1158/1078-0432.22471553.v1
Autor:
Philippe Moreau, Jesús F. San-Miguel, Anil Singhal, Bruno Paiva, Anita Reddy, James P. Sheridan, Scott Gulbranson, Shekman Wong, Katja Weisel, Xavier Leleu, Andrzej J. Jakubowiak, Joaquín Martínez-López, Andreas Guenther, Marc S. Raab, Jesús G. Berdeja, María-Victoria Mateos, Daniel E.H. Afar, Rajneesh Nath, Ravi Vij
Purpose:ABBV-838 is an antibody–drug conjugate targeting a unique epitope of CD2 subset 1, a cell-surface glycoprotein expressed on multiple myeloma cells. This phase I/Ib first-in-human, dose-escalation study (trial registration ID: NCT02462525) e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b92335383f066e12e00748e447cf92c
https://doi.org/10.1158/1078-0432.c.6527927.v1
https://doi.org/10.1158/1078-0432.c.6527927.v1
Autor:
Philippe Moreau, Jesús F. San-Miguel, Anil Singhal, Bruno Paiva, Anita Reddy, James P. Sheridan, Scott Gulbranson, Shekman Wong, Katja Weisel, Xavier Leleu, Andrzej J. Jakubowiak, Joaquín Martínez-López, Andreas Guenther, Marc S. Raab, Jesús G. Berdeja, María-Victoria Mateos, Daniel E.H. Afar, Rajneesh Nath, Ravi Vij
Study design schematic. N, number of patients in each dose group; PK/PD, pharmacokinetics/pharmacodynamics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b8ad54bf2863964b9eb23f6cb05576d
https://doi.org/10.1158/1078-0432.22471556
https://doi.org/10.1158/1078-0432.22471556
Autor:
Sham Mailankody, Jeffrey V. Matous, Saurabh Chhabra, Michaela Liedtke, Surbhi Sidana, Olalekan O. Oluwole, Shahbaz Malik, Rajneesh Nath, Faiz Anwer, Jose Carlos Cruz, Myo Htut, Erin E. Karski, Wade Lovelace, Myles Dillon, Eric Butz, Wendy Ying, Arun Balakumaran, Shaji K. Kumar
Publikováno v:
Nature Medicine.